共 50 条
- [21] Precision Retargeting: A Selective Covalent Inhibitor Illuminates CDK7 BiologyCELL CHEMICAL BIOLOGY, 2019, 26 (06): : 779 - 780Jones, Lyn H.
- [22] Development of a Selective CDK7 Covalent Inhibitor Reveals Predominant Cell-Cycle PhenotypeCELL CHEMICAL BIOLOGY, 2019, 26 (06) : 792 - +Olson, Calla M.Liang, YankeLeggett, AlanPark, Woojun D.Li, LianboMills, Caitlin E.Elsarrag, Selma Z.Ficarro, Scott B.Zhang, TinghuDuester, RobertGeyer, MatthiasSim, TaeboMarto, Jarrod A.Sorger, Peter K.Westover, Ken D.Lin, Charles Y.Kwiatkowski, NicholasGray, Nathanael S.
- [23] CDK7 Inhibition Potentiates Genome Instability Triggering Anti-tumor Immunity in Small Cell Lung CancerCANCER CELL, 2020, 37 (01) : 37 - +Zhang, HuaChristensen, Camilla L.Dries, RubenOser, Matthew G.Deng, JiehuiDiskin, BrianLi, FeiPan, YuanwangZhang, XuzhuYin, YandongPapadopoulos, EleniPyon, ValThakurdin, CassandraKwiatkowski, NicholasJani, KandarpRabin, Alexandra R.Castro, Dayanne M.Chen, TingSilver, HeatherHuang, QingyuanBulatovic, MirnaDowling, Catriona M.Sundberg, BelenLeggett, AlanRanieri, MichelaHan, HanLi, ShuaiYang, AnnanLabbe, Kristen E.Almonte, ChristinaSviderskiy, Vladislav O.Quinn, MaxDonaghue, JackWang, Eric S.Zhang, TinghuHe, ZhixiangVelcheti, VamsidharHammerman, Peter S.Freeman, Gordon J.Bonneau, RichardKaelin, William G., Jr.Sutherland, Kate D.Kersbergen, ArienaAguirre, Andrew J.Yuan, Guo-ChengRothenberg, EliMiller, GeorgeGray, Nathanael S.Wong, Kwok-Kin
- [24] Discovery and Characterization of SY-1365, a Selective, Covalent Inhibitor of CDK7CANCER RESEARCH, 2019, 79 (13) : 3479 - 3491Hu, ShanhuMarineau, Jason J.Rajagopal, NishaHamman, Kristin B.Choi, Yoon JongSchmidt, Darby R.Ke, NanJohannessen, LivBradley, Michael J.Orlando, David A.Alnemy, Sydney R.Ren, YixuanCiblat, StephaneWinter, Dana K.Kabro, AnzhelikaSprott, Kevin T.Hodgson, J. GraemeFritz, Christian C.Carulli, John P.di Tomaso, EmmanuelleOlson, Eric R.
- [25] ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer TreatmentMOLECULAR CANCER THERAPEUTICS, 2018, 17 (06) : 1156 - 1166Patel, HetalPeriyasamy, ManikandanSava, Georgina P.Bondke, AlexanderSlafer, Brian W.Kroll, Sebastian H. B.Barbazanges, MarionStarkey, RichardOttaviani, SilviaHarrod, AlisonAboagye, Eric O.Buluwela, LakiFuchter, Matthew J.Barrett, Anthony G. M.Coombes, R. CharlesAli, Simak
- [26] ICEC0942, an orally bioavailable selective inhibitor of CDK7 for breast cancerBREAST CANCER RESEARCH AND TREATMENT, 2016, 159 (01) : 195 - 195Ali, SimakPatel, HetalPeriyasamy, ManikandanBondke, AlexanderSlafer, Brian W.Ottaviani, SilviaHarrod, AlisonBuluwela, LakiFuchter, Matthew J.Barrett, Anthony G. M.Coombes, R. Charles
- [27] Profound anti-tumor efficacy of dual CDK7 and PD1 blockade in novel syngeneic prostate cancer modelsCANCER RESEARCH, 2022, 82 (12)Wise, DavidPereira, Luiza DoroWu, JianshengFebles, Victor R. AdornoMelamed, JonathanDeng, Fang-MingZhang, HuaWong, Kwok-Kin
- [28] Anti-tumor activity of ASP3026, - A novel and selective ALK inhibitor -CANCER RESEARCH, 2011, 71Kuromitsu, SadaoMori, MasamichiShimada, ItsuroKondoh, YutakaShindoh, NobuakiSoga, TakatoshiFurutani, TakashiKonagai, SatoshiSakagami, HidekiNakata, MariUeno, YokoSaito, RikaSasamata, MasaoMano, HiroyukiKudou, Masafumi
- [29] SY5609, a Potent and Selective CDK7 Inhibitor, Potentiates BTK Inhibitor Activity in Mantle Cell Lymphoma Preclinical ModelsBLOOD, 2021, 138Johannessen, LivHenry, SusanSawant, PriyankaD'Ippolito, AnthonyKe, NanLefkowitz, ArielEaton, MatthewDworakowski, WojciechRosario, MariaHodgson, Graeme
- [30] Sy-1365, a Potent and Selective CDK7 Inhibitor, Exhibits Anti-Tumor Activity in Preclinical Models of Hematologic Malignancies, and Demonstrates Interactions with the BCL-XL/BCL2 Mitochondrial Apoptosis Signaling Pathway in LeukemiaBLOOD, 2017, 130Hodgson, GraemeJohannessen, LivRajagopal, NishaHu, ShanhuOrlando, DavidEaton, MatthewMcKeown, MichaelTyner, Jeffrey W.Kurtz, Stephen E.Sprott, KevinFritz, ChristianDi Tomaso, Emmanuelle